Association of tamoxifen with meningioma
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 25 (1) , 29-33
Abstract
Previous studies suggest that hormone therapy may play an important role in the development of meningioma. However, it is unclear whether medication with tamoxifen can prevent meningioma. Our study cohort included all women who were diagnosed with breast cancer between 1961 and 2010, and a total of 227 535 women were identified with breast cancer with a median age at diagnosis of 63 years. Women diagnosed with breast cancer after 1987 were defined as tamoxifen exposed; those diagnosed with breast cancer before or during 1987 were defined as not exposed to tamoxifen. Standardized incidence ratios (SIRs) were used to calculate the risk of subsequent meningioma. Of these women, 223 developed meningioma. For women without tamoxifen exposure, the risk of meningioma was significantly increased, with an SIR of 1.54 (95% confidence interval 1.30–1.81); the risk was not increased in those with tamoxifen exposure (SIR=1.06, 95% confidence interval 0.84–1.32). The increased risk of meningioma in women without tamoxifen exposure persisted during 10 years of follow-up. In this historical cohort study, we found that women diagnosed with breast cancer but not treated with tamoxifen had an increased incidence of meningioma, whereas the incidence was close to that of the general population in patients treated with tamoxifen. This suggests that tamoxifen may prevent the development of meningioma.Keywords
This publication has 37 references indexed in Scilit:
- A review of human carcinogens—Part D: radiationThe Lancet Oncology, 2009
- The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studiesInternational Journal of Cancer, 2009
- How effective are breast cancer screening programmes by mammography? Review of the current evidenceEuropean Journal of Cancer, 2009
- Exogenous hormone use and meningioma riskCancer, 2007
- MOLECULAR GENETICS OF MENINGIOMASNeurosurgery, 2007
- Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas.2000
- Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levelsBreast Cancer Research and Treatment, 2000
- Primary brain tumours as second primary: A novel association between meningioma and colorectal cancerInternational Journal of Cancer, 1999
- Progesterone and estrogen receptors in meningiomas: prognostic considerationsJournal of Neurosurgery, 1997
- A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group studyJournal of Neuro-Oncology, 1993